Avital Beeri Shnerb

MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer

Manu Prasad, Jonathan Zorea, Sankar Jagadeeshan et al. · Journal for ImmunoTherapy of Cancer · 2022 · 69 citations · Full text

Medicine, Immunology, Oncology +17

Activation of the <scp>EGFR</scp> / <scp>PI3K</scp> / <scp>AKT</scp> pathway limits the efficacy of trametinib treatment in head and neck cancer

Ofra Novoplansky, Avital Beeri Shnerb, Divyasree Marripati et al. · Molecular Oncology · 2023 · 33 citations · Full text

Medicine, Oncology, Pharmacology +17

Mutated HRAS Activates YAP1–AXL Signaling to Drive Metastasis of Head and Neck Cancer

Sankar Jagadeeshan, Manu Prasad, Mai Badarni et al. · Cancer Research · 2023 · 24 citations · Full text

Medicine, Cancer Biology, Oncology +17